Home

Brett R. Hagen, Chief Accounting Officer: Kalaris Therapeutics KLRS Sell · Filed 23/07/21

Trade details

Type
Insider sale
Amount
$1,217.52
Shares · price
342 sh · $3.56 a share
Held after
129,170 sh
Trade date
23/07/19
Filed
23/07/21
Days to filing
2 days

Sold 0.3% of holdings

Share of holding sold
0.3%

Kalaris Therapeutics trades, last 26 weeks

What else happened in Kalaris Therapeutics around then

Filed or reported within 30 days of the trade day · 23/06/19~23/08/18

Brett R. Hagen's recent trades

  • Brett R. Hagen

    SellKalaris Therapeutics

    $12.9K

    Filed 03/23

  • Brett R. Hagen

    Planned saleKalaris Therapeutics

    $12.9K

    Filed 03/20

  • Brett R. Hagen

    SellKalaris Therapeutics

    $8,136

    Filed 25/03/27

  • Brett R. Hagen

    SellKalaris Therapeutics

    $968

    Filed 25/02/24

  • Brett R. Hagen

    Planned saleKalaris Therapeutics

    $967

    Filed 25/02/24

Brett R. Hagen, CAO — sold $1,218 of Kalaris Therapeutics KLRS · 0.3% of holdings · 10b5-1 plan | Whalegun